185 related articles for article (PubMed ID: 20025947)
1. Inclusion of poorly soluble drugs in highly ordered mesoporous silica nanoparticles.
Thomas MJ; Slipper I; Walunj A; Jain A; Favretto ME; Kallinteri P; Douroumis D
Int J Pharm; 2010 Mar; 387(1-2):272-7. PubMed ID: 20025947
[TBL] [Abstract][Full Text] [Related]
2. Inclusion of water insoluble drugs in amorphous silica nanoparticles.
Patil A; Lafarga AA; Chebrot M; Lamprou DA; Urquhart A; Douroumis D
J Biomed Nanotechnol; 2012 Aug; 8(4):550-7. PubMed ID: 22852464
[TBL] [Abstract][Full Text] [Related]
3. Monodispersed mesoporous silica nanoparticles with very large pores for enhanced adsorption and release of DNA.
Gao F; Botella P; Corma A; Blesa J; Dong L
J Phys Chem B; 2009 Feb; 113(6):1796-804. PubMed ID: 19152258
[TBL] [Abstract][Full Text] [Related]
4. Successfully tailoring the pore size of mesoporous silica nanoparticles: exploitation of delivery systems for poorly water-soluble drugs.
Jia L; Shen J; Li Z; Zhang D; Zhang Q; Duan C; Liu G; Zheng D; Liu Y; Tian X
Int J Pharm; 2012 Dec; 439(1-2):81-91. PubMed ID: 23078857
[TBL] [Abstract][Full Text] [Related]
5. Ultrafast enzyme immobilization over large-pore nanoscale mesoporous silica particles.
Sun J; Zhang H; Tian R; Ma D; Bao X; Su DS; Zou H
Chem Commun (Camb); 2006 Mar; (12):1322-4. PubMed ID: 16538261
[TBL] [Abstract][Full Text] [Related]
6. The cytotoxic activity of amorphous silica nanoparticles is mainly influenced by surface area and not by aggregation.
Rabolli V; Thomassen LC; Uwambayinema F; Martens JA; Lison D
Toxicol Lett; 2011 Oct; 206(2):197-203. PubMed ID: 21803137
[TBL] [Abstract][Full Text] [Related]
7. Nanoparticles of mesoporous SO3H-functionalized Si-MCM-41 with superior proton conductivity.
Marschall R; Bannat I; Feldhoff A; Wang L; Lu GQ; Wark M
Small; 2009 Apr; 5(7):854-9. PubMed ID: 19226596
[TBL] [Abstract][Full Text] [Related]
8. Modified mesoporous silica nanoparticles for enhancing oral bioavailability and antihypertensive activity of poorly water soluble valsartan.
Biswas N
Eur J Pharm Sci; 2017 Mar; 99():152-160. PubMed ID: 27993684
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of novel core-shell structured dual-mesoporous silica nanospheres and their application for enhancing the dissolution rate of poorly water-soluble drugs.
Wu C; Sun X; Zhao Z; Zhao Y; Hao Y; Liu Y; Gao Y
Mater Sci Eng C Mater Biol Appl; 2014 Nov; 44():262-7. PubMed ID: 25280705
[TBL] [Abstract][Full Text] [Related]
10. Effect of size on the cellular endocytosis and controlled release of mesoporous silica nanoparticles for intracellular delivery.
Gan Q; Dai D; Yuan Y; Qian J; Sha S; Shi J; Liu C
Biomed Microdevices; 2012 Apr; 14(2):259-70. PubMed ID: 22124885
[TBL] [Abstract][Full Text] [Related]
11. Spherical mesoporous silica nanoparticles for loading and release of the poorly water-soluble drug telmisartan.
Zhang Y; Zhi Z; Jiang T; Zhang J; Wang Z; Wang S
J Control Release; 2010 Aug; 145(3):257-63. PubMed ID: 20450945
[TBL] [Abstract][Full Text] [Related]
12. Mesoporous silica nanoparticles for increasing the oral bioavailability and permeation of poorly water soluble drugs.
Zhang Y; Wang J; Bai X; Jiang T; Zhang Q; Wang S
Mol Pharm; 2012 Mar; 9(3):505-13. PubMed ID: 22217205
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, amino-functionalization of mesoporous silica and its adsorption of Cr(VI).
Li J; Miao X; Hao Y; Zhao J; Sun X; Wang L
J Colloid Interface Sci; 2008 Feb; 318(2):309-14. PubMed ID: 18036539
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, self-assembly, and in vitro doxorubicin release behavior of dendron-like/linear/dendron-like poly(epsilon-caprolactone)-b-poly(ethylene glycol)-b-poly(epsilon-caprolactone) triblock copolymers.
Yang Y; Hua C; Dong CM
Biomacromolecules; 2009 Aug; 10(8):2310-8. PubMed ID: 19618927
[TBL] [Abstract][Full Text] [Related]
15. Physical state and dissolution of ibuprofen formulated by co-spray drying with mesoporous silica: effect of pore and particle size.
Shen SC; Ng WK; Chia L; Hu J; Tan RB
Int J Pharm; 2011 May; 410(1-2):188-95. PubMed ID: 21419202
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and characterization of pore size-tunable magnetic mesoporous silica nanoparticles.
Zhang J; Li X; Rosenholm JM; Gu HC
J Colloid Interface Sci; 2011 Sep; 361(1):16-24. PubMed ID: 21689824
[TBL] [Abstract][Full Text] [Related]
17. The effect of PEGylation of mesoporous silica nanoparticles on nonspecific binding of serum proteins and cellular responses.
He Q; Zhang J; Shi J; Zhu Z; Zhang L; Bu W; Guo L; Chen Y
Biomaterials; 2010 Feb; 31(6):1085-92. PubMed ID: 19880176
[TBL] [Abstract][Full Text] [Related]
18. Physical state of poorly water soluble therapeutic molecules loaded into SBA-15 ordered mesoporous silica carriers: a case study with itraconazole and ibuprofen.
Mellaerts R; Jammaer JA; Van Speybroeck M; Chen H; Van Humbeeck J; Augustijns P; Van den Mooter G; Martens JA
Langmuir; 2008 Aug; 24(16):8651-9. PubMed ID: 18630936
[TBL] [Abstract][Full Text] [Related]
19. Controlled synthesis of highly dispersed platinum nanoparticles in ordered mesoporous carbons.
Liu SH; Lu RF; Huang SJ; Lo AY; Chien SH; Liu SB
Chem Commun (Camb); 2006 Aug; (32):3435-7. PubMed ID: 16896486
[TBL] [Abstract][Full Text] [Related]
20. Study on formulation variables of methotrexate loaded mesoporous MCM-41 nanoparticles for dissolution enhancement.
Vadia N; Rajput S
Eur J Pharm Sci; 2012 Jan; 45(1-2):8-18. PubMed ID: 22067974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
